Beacon Pointe Wealth Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$1.13M Sell
4,669
-588
-11% -$130K 0.21% 93
2019
Q3
$1.02M Sell
5,257
-424
-7% -$81.4K 0.21% 99
2019
Q2
$1.05M Buy
5,681
+116
+2% +$20.8K 0.22% 96
2019
Q1
$1.05M Buy
5,565
+312
+6% +$59.6K 0.24% 88
2018
Q4
$1.02M Buy
+5,253
New +$1.02M 0.37% 68

Other funds holding AMGN

Beacon Pointe Wealth Advisors's AMGN Position: Q4 2019 in Review

Beacon Pointe Wealth Advisors reduced its Amgen (AMGN) stake by 11% in Q4 2019, selling an estimated $130K and leaving 4,669 shares worth $1.13M. The position accounts for 0.21% of the portfolio, ranked #93.

Beacon Pointe Wealth Advisors first reported a position in AMGN in Q4 2018 and has held it in 5 quarters since. 2,107 funds tracked by Wall St. Rank hold AMGN as of Q4 2019.

  • Beacon Pointe Wealth Advisors held 4,669 shares of Amgen worth $1.13M as of Q4 2019.
  • Beacon Pointe Wealth Advisors sold 588 Amgen shares in Q4 2019, an estimated $130K.
  • Amgen made up 0.21% of Beacon Pointe Wealth Advisors's portfolio in Q4 2019, its #93 holding.
  • Beacon Pointe Wealth Advisors first reported a position in Amgen in Q4 2018 and has held it in 5 quarters since.
  • 2,107 funds tracked by Wall St. Rank held Amgen as of Q4 2019.

Based on Beacon Pointe Wealth Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.